Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Some psychiatric medications can cause hair loss, but it usually grows back after adjusting the medication.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Improving skin barrier and using antifungal treatments can help manage dandruff.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

*Acorus calamus* has many medicinal benefits but needs more safety research.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.